{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:27:00Z","timestamp":1793114820249,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372989"],"award-info":[{"award-number":["82372989"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172913"],"award-info":[{"award-number":["82172913"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jare.2025.10.022","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:49:42Z","timestamp":1760662182000},"page":"819-835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Targeting PLOD2 induces epithelioid differentiation and improves therapeutic response in sarcomatoid renal cell carcinoma"],"prefix":"10.1016","volume":"85","author":[{"given":"Xiangyu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongkui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3752-8389","authenticated-orcid":false,"given":"Yu","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xichen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixian","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jare.2025.10.022_b0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours[J]","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"issue":"10","key":"10.1016\/j.jare.2025.10.022_b0010","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/PAS.0b013e318299f0fb","article-title":"The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters[J]","volume":"37","author":"Delahunt","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.jare.2025.10.022_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2019.01.005","article-title":"Sarcomatoid renal cell carcinoma: population-based study of 879 patients[J]","volume":"17","author":"Alevizakos","year":"2019","journal-title":"Clin Genitourin Cancer"},{"issue":"11","key":"10.1016\/j.jare.2025.10.022_b0020","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/j.1464-410X.2011.10785.x","article-title":"Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma[J]","volume":"109","author":"Shuch","year":"2012","journal-title":"BJU Int"},{"issue":"12","key":"10.1016\/j.jare.2025.10.022_b0025","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41585-020-00382-9","article-title":"Sarcomatoid renal cell carcinoma: biology, natural history and management","volume":"17","author":"Blum","year":"2020","journal-title":"Nat Rev Urol"},{"issue":"1","key":"10.1016\/j.jare.2025.10.022_b0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-5347(05)65384-0","article-title":"Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma[J]","volume":"167","author":"Mian","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.jare.2025.10.022_b0035","article-title":"The significance of sarcomatoid and rhabdoid dedifferentiation in renal cell carcinoma[J]","volume":"33","author":"Hahn","year":"2022","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.jare.2025.10.022_b0040","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1634\/theoncologist.2011-0227","article-title":"Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies","volume":"17","author":"Shuch","year":"2012","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.jare.2025.10.022_b0045","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00000478-200404000-00002","article-title":"Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome","volume":"28","author":"Cheville","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.jare.2025.10.022_b0050","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/cncr.21288","article-title":"Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation[J]","volume":"104","author":"Jones","year":"2005","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.jare.2025.10.022_b0055","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.eururo.2016.01.051","article-title":"Genomic characterization of renal cell carcinoma with sarcomatoid dedifferentiation pinpoints recurrent genomic alterations","volume":"70","author":"Malouf","year":"2016","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.jare.2025.10.022_b0060","doi-asserted-by":"crossref","first-page":"134.e9","DOI":"10.1016\/j.urolonc.2020.10.019","article-title":"Outcomes of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation to immune checkpoint inhibitors","volume":"39","author":"Chahoud","year":"2021","journal-title":"Urol Oncol"},{"issue":"4","key":"10.1016\/j.jare.2025.10.022_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2014.11.021","article-title":"Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation: natural history and outcomes after surgical resection with curative intent[J]","volume":"33","author":"Merrill","year":"2015","journal-title":"Urol Oncol"},{"issue":"3","key":"10.1016\/j.jare.2025.10.022_b0070","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/bju.12781","article-title":"A novel prognostic model for patients with sarcomatoid renal cell carcinoma","volume":"115","author":"Zhang","year":"2015","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.jare.2025.10.022_b0075","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/cncr.23520","article-title":"Survival rates after resection for localized kidney cancer: 1989 to 2004[J]","volume":"113","author":"Russo","year":"2008","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.jare.2025.10.022_b0080","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/003130299104945","article-title":"Sarcomatoid renal carcinoma: the final common dedifferentiation pathway of renal epithelial malignancies[J]","volume":"31","author":"Delahunt","year":"1999","journal-title":"Pathology"},{"issue":"12","key":"10.1016\/j.jare.2025.10.022_b0085","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/jclinpath-2011-200216","article-title":"Sarcomatoid renal cell carcinoma is an example of epithelial\u2013mesenchymal transition[J]","volume":"64","author":"Conant","year":"2011","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jare.2025.10.022_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216496","article-title":"Epigenetic inhibition of CTCF by HN1 promotes dedifferentiation and stemness of anaplastic thyroid cancer[J]","volume":"580","author":"Pan","year":"2024","journal-title":"Cancer Lett"},{"issue":"4","key":"10.1016\/j.jare.2025.10.022_b0095","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells[J]","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jare.2025.10.022_b0100","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.biopha.2017.04.023","article-title":"PLOD2 in cancer research","volume":"90","author":"Du","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"10.1016\/j.jare.2025.10.022_b0105","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s41419-023-06298-7","article-title":"Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jare.2025.10.022_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.985641","article-title":"Sarcomatoid-associated gene risk index for clear cell renal cell carcinoma","volume":"13","author":"Zuo","year":"2022","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.jare.2025.10.022_b0115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ccell.2022.12.001","article-title":"Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness","volume":"41","author":"Li","year":"2023","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.jare.2025.10.022_b0120","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1158\/1078-0432.CCR-15-0876","article-title":"A patient-derived, pan-cancer EMT signature identifies global molecular alterations and immune target enrichment following epithelial-to-mesenchymal transition","volume":"22","author":"Mak","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.jare.2025.10.022_b0125","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/s41467-020-14700-7","article-title":"Inhibiting WNT and NOTCH in renal cancer stem cells and the implications for human patients","volume":"11","author":"Fendler","year":"2020","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.jare.2025.10.022_b0130","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s43018-023-00595-y","article-title":"Cancer cell plasticity during tumor progression, metastasis and response to therapy","volume":"4","author":"P\u00e9rez-Gonz\u00e1lez","year":"2023","journal-title":"Nat Cancer"},{"issue":"2","key":"10.1016\/j.jare.2025.10.022_b0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrc.2017.103","article-title":"Differentiation therapy revisited","volume":"18","author":"de Th\u00e9","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jare.2025.10.022_b0140","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.semcancer.2023.10.003","article-title":"From shape-shifting embryonic cells to oncology: the fascinating history of epithelial mesenchymal transition","volume":"96","author":"Akhurst","year":"2023","journal-title":"Semin Cancer Biol"},{"issue":"17","key":"10.1016\/j.jare.2025.10.022_b0145","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1038\/s41388-020-1234-3","article-title":"Modeling clear cell renal cell carcinoma and therapeutic implications","volume":"39","author":"Wolf","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.jare.2025.10.022_b0150","doi-asserted-by":"crossref","first-page":"15165","DOI":"10.1038\/ncomms15165","article-title":"Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection","volume":"8","author":"Sinha","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2025.10.022_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.871252","article-title":"Models of renal cell carcinoma used to investigate molecular mechanisms and develop new therapeutics","volume":"12","author":"Shapiro","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.jare.2025.10.022_b0160","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s13046-018-0952-7","article-title":"Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity","volume":"37","author":"Trotta","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.jare.2025.10.022_b0165","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/sj.bjc.6603796","article-title":"High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile","volume":"96","author":"Baldewijns","year":"2007","journal-title":"Br J Cancer"},{"issue":"30","key":"10.1016\/j.jare.2025.10.022_b0170","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1200\/JCO.2007.12.1087","article-title":"Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma","volume":"25","author":"Leibovich","year":"2007","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jare.2025.10.022_b0175","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.eururo.2008.10.014","article-title":"Expression of aquaporin 1 in primary renal tumors: a prognostic indicator for clear-cell renal cell carcinoma","volume":"56","author":"Huang","year":"2009","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.jare.2025.10.022_b0180","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4132\/jptm.2023.06.17","article-title":"Loss of aquaporin-1 expression is associated with worse clinical outcomes in clear cell renal cell carcinoma: an immunohistochemical study","volume":"57","author":"Lee","year":"2023","journal-title":"J Pathol Transl Med"},{"issue":"6","key":"10.1016\/j.jare.2025.10.022_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114350","article-title":"Epigenomic signatures of sarcomatoid differentiation to guide the treatment of renal cell carcinoma","volume":"43","author":"El Zarif","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.jare.2025.10.022_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.euo.2024.02.007","article-title":"Stratification of patients with renal cell carcinoma by the abundance of sarcomatoid features reveals differences in survival and the underlying pathobiology","author":"Salgia","year":"2024","journal-title":"Eur Urol Oncol"},{"issue":"854","key":"10.1016\/j.jare.2025.10.022_b0195","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abq4888","article-title":"DCLK1 induces a pro-tumorigenic phenotype to drive gastric cancer progression","volume":"17","author":"Afshar-Sterle","year":"2024","journal-title":"Sci Signal"},{"issue":"5","key":"10.1016\/j.jare.2025.10.022_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052622","article-title":"TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues","volume":"22","author":"Bartha","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.10.022_b0205","doi-asserted-by":"crossref","first-page":"8592","DOI":"10.12659\/MSM.910761","article-title":"Lysyl hydroxylase inhibition by minoxidil blocks collagen deposition and prevents pulmonary fibrosis via TGF-\u03b21\/Smad3 signaling pathway","volume":"24","author":"Shao","year":"2018","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jare.2025.10.022_b0210","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12935-017-0420-z","article-title":"Hypoxia and TGF-\u03b21 induced PLOD2 expression improve the migration and invasion of cervical cancer cells by promoting epithelial-to-mesenchymal transition (EMT) and focal adhesion formation","volume":"17","author":"Xu","year":"2017","journal-title":"Cancer Cell Int"},{"issue":"10","key":"10.1016\/j.jare.2025.10.022_b0215","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00345-016-1780-z","article-title":"Comparison of oncologic outcomes between sarcomatoid and clear cell renal cell carcinoma","volume":"34","author":"Trudeau","year":"2016","journal-title":"World J Urol"},{"issue":"3","key":"10.1016\/j.jare.2025.10.022_b0220","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.juro.2017.04.067","article-title":"Outcomes of patients with renal cell carcinoma and sarcomatoid dedifferentiation treated with nephrectomy and systemic therapies: comparison between the cytokine and targeted therapy eras","volume":"198","author":"Keskin","year":"2017","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.jare.2025.10.022_b0225","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1073\/pnas.1525735113","article-title":"Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma","volume":"113","author":"Bi","year":"2016","journal-title":"PNAS"},{"issue":"21","key":"10.1016\/j.jare.2025.10.022_b0230","doi-asserted-by":"crossref","first-page":"6686","DOI":"10.1158\/1078-0432.CCR-17-1057","article-title":"Sarcomatoid renal cell carcinoma has a distinct molecular pathogenesis, driver mutation profile, and transcriptional landscape","volume":"23","author":"Wang","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jare.2025.10.022_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/genes13050787","article-title":"PLOD family: a novel biomarker for prognosis and personalized treatment in soft tissue sarcoma","volume":"13","author":"Gong","year":"2022","journal-title":"Genes (Basel)"},{"issue":"4","key":"10.1016\/j.jare.2025.10.022_b0240","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.matbio.2005.04.002","article-title":"Minoxidil exerts different inhibitory effects on gene expression of lysyl hydroxylase 1, 2, and 3: implications for collagen cross-linking and treatment of fibrosis","volume":"24","author":"Zuurmond","year":"2005","journal-title":"Matrix Biol"},{"issue":"3","key":"10.1016\/j.jare.2025.10.022_b0245","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jaad.2025.05.1363","article-title":"Safety and tolerability of low-dose oral minoxidil in patients aged 65 or older: a multicenter study of 321 patients","volume":"93","author":"Jimenez-Cauhe","year":"2025","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225008185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225008185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:33:59Z","timestamp":1785897239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123225008185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":49,"alternative-id":["S2090123225008185"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2025.10.022","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting PLOD2 induces epithelioid differentiation and improves therapeutic response in sarcomatoid renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2025.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}